key: cord-280794-k591vqji
authors: Bauer, Melissa E.; Chiware, Ruth; Pancaro, Carlo
title: Neuraxial Procedures in COVID-19–Positive Parturients: A Review of Current Reports
date: 2020-04-20
journal: Anesth Analg
DOI: 10.1213/ane.0000000000004831
sha: 
doc_id: 280794
cord_uid: k591vqji

nan

To the Editor C oronavirus Disease 2019 (COVID-19) in pregnancy presents a unique challenge given the limited data on anesthetic management. Other viral diseases, such as H1N1 influenza and severe acute respiratory syndrome (SARS), have been associated with severe respiratory compromise in pregnancy. Because anesthesiologists must take into account the risk of meningitis or encephalitis associated with neuraxial procedures in the setting of untreated viremia, we reviewed publications reporting outcomes in COVID-19-positive pregnant women in the current pandemic in an attempt to address this concern.

A literature search for all articles reporting confirmed COVID-19 infection at the time of delivery revealed 4 publications reporting 14 cases admitted between January 20, 2020 and February 6, 2020. In reports with no information about neuraxial use, authors were contacted via e-mail to gather that information (13 of 14). There were no reported neurologic sequelae after neuraxial procedures in any of these cases. [1] [2] [3] [4] Case details are reported in the Table. Thirteen patients (93%) underwent cesarean delivery; 6 (43%) were preterm (<37 weeks of gestation). Fever was present in 10 (71%) patients and 2 (14%) patients were treated with antiviral medication before the neuraxial procedure. Computed tomography or chest X-ray evidence of pneumonia was reported in all patients before delivery. Clinical severity in symptoms was not always reported, but ranged from resolution of respiratory symptoms to noninvasive ventilation at the time of cesarean delivery. White blood cell (WBC) count levels were not elevated in 13 (86%) patients. One patient presented with a WBC count of 8.7 × 10 6 /L and received daily methylprednisolone for inflammation. Her WBC count subsequently increased to 22.9 × 10 6 /L. 1 Thrombocytopenia was reported in 2 pregnant patients without preeclampsia with the nadir being platelet counts of 81,000 and 91,000 × 10 6 /L, respectively. 1,2 A case series of 138 COVID-19-positive nonpregnant patients reported about one-third of patients had thrombocytopenia (<150,000 × 10 6 /L) regardless of severity of illness. 5 Assessing whether a parturient with COVID-19 is suitable for neuraxial procedures should focus on Neuraxial Procedures in COVID-19-Positive Parturients: A Review of Current Reports the risks of general anesthesia compared with neuraxial anesthesia. Labor epidural procedures should also be considered as a means to avoid general anesthesia because the in-situ catheter allows extension for cesarean delivery anesthesia should an urgent cesarean delivery be needed. In general, the risk of causing meningitis or encephalitis is extremely low with neuraxial procedures, even in infected patients. Febrile patients with altered mental status commonly undergo diagnostic lumbar punctures. It is thought that patients who subsequently developed meningitis following lumbar puncture were early in the progression of the disease (before cerebrospinal fluid [CSF] evidence of disease) or the meningitis was due to the pathogenic nature of the specific bacteria rather than seeding of the bacteria in the subarachnoid space. 6 COVID-19 patients with hypoxia and concomitant physiologically decreased functional residual capacity from pregnancy will be likely to become more hypoxic, develop further atelectasis with intubation and mechanical ventilation, and possibly require postoperative critical care admission. Before performing a neuraxial procedure in these patients, it would be advisable to review a recent platelet count given that one-third of patients with COVID-19 infection have been reported to have thrombocytopenia compared with 7%-12% of patients during pregnancy alone. 7 In pregnant women, a platelet count of 70,000 × 10 6 /L has a low risk for spinal epidural hematoma, and lower levels should be considered in cases such as these with a high risk for respiratory compromise with general anesthesia. 8 Although 2 of the 14 cases were reported to have received antiviral treatment before the neuraxial procedure, there is no currently accepted antiviral medication known to be effective for COVID-19, according to the Centers for Disease Control and Prevention. In conclusion, we believe the real risk of general anesthesia outweighs the theoretical risk of causing meningitis/encephalitis by performing neuraxial procedures, and we therefore recommend performing neuraxial procedures in parturients with COVID-19 unless otherwise contraindicated.

Lack of vertical transmission of severe acute respiratory syndrome Coronavirus 2, China. Emerg Infect Dis J

Coronavirus disease 2019 (COVID-19) during pregnancy: a case series

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery

Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan

Risk factors for development of bacterial meningitis among children with occult bacteremia

American College of Obstetricians and Gynecologists' Committee on Practice Bulletins, Turrentine M. ACOG practice bulletin no. 207: thrombocytopenia in pregnancy

Multicenter Perioperative Outcomes Group Investigators. Risk of epidural hematoma after neuraxial techniques in thrombocytopenic parturients: a report from the multicenter perioperative outcomes group


